Figure 1 (IMAGE)

Tohoku University

Figure 1

Caption

Metastatic lymph node targeted immune checkpoint blockade (ICB) elicits strong therapeutic response and ameliorates ICB-induced interstitial pneumonia.

Credit

Tohoku University

Usage Restrictions

Reporters may use freely these materials in news coverage with appropriate credit information.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.